Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Gains from Investment Securities: 2015-2024

Historic Gains from Investment Securities for Nutex Health (NUTX) over the last 9 years, with FY2024 value amounting to $4.6 million.

  • Nutex Health's Gains from Investment Securities rose 19152.89% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 8571.92%. This contributed to the annual value of $4.6 million for FY2024, which is 3281.22% up from last year.
  • As of FY2024, Nutex Health's Gains from Investment Securities stood at $4.6 million, which was up 3281.22% from $3.5 million recorded in FY2023.
  • In the past 5 years, Nutex Health's Gains from Investment Securities registered a high of $4.6 million during FY2024, and its lowest value of $1.2 million during FY2020.
  • In the last 5 years, Nutex Health's Gains from Investment Securities had a median value of $2.9 million in 2021 and averaged $2.8 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 14480.56% in 2021, then tumbled by 4015.24% in 2022.
  • Over the past 5 years, Nutex Health's Gains from Investment Securities (Annual) stood at $1.2 million in 2020, then skyrocketed by 144.81% to $2.9 million in 2021, then crashed by 40.15% to $1.7 million in 2022, then surged by 102.45% to $3.5 million in 2023, then surged by 32.81% to $4.6 million in 2024.
  • Its Gains from Investment Securities stands at $4.6 million for FY2024, versus $3.5 million for FY2023 and $1.7 million for FY2022.